| 000 | 01075 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250515211321.0 | ||
| 264 | 0 | _c20100701 | |
| 008 | 201007s 0 0 eng d | ||
| 022 | _a1873-4286 | ||
| 024 | 7 |
_a10.2174/138161210790112782 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPress, R R | |
| 245 | 0 | 0 |
_aIndividualizing calcineurin inhibitor therapy in renal transplantation--current limitations and perspectives. _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical design _c2010 |
||
| 300 |
_a176-86 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aCalcineurin Inhibitors |
| 650 | 0 | 4 |
_aCyclosporine _xpharmacokinetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aKidney Transplantation |
| 650 | 0 | 4 |
_aTacrolimus _xpharmacokinetics |
| 700 | 1 | _ade Fijter, J W | |
| 700 | 1 | _aGuchelaar, H-J | |
| 773 | 0 |
_tCurrent pharmaceutical design _gvol. 16 _gno. 2 _gp. 176-86 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/138161210790112782 _zAvailable from publisher's website |
| 999 |
_c19572986 _d19572986 |
||